Effects of steal-prone anatomy on intraoperative myocardial ischemia  by Leung, Jacqueline M. et al.
JACC Vol. 20, No.5 
November I, 1992:1205-12 
1205 
Effects of Steal-Prone Anatomy on Intraoperative Myocardial Ischemia 
JACQUELINE M. LEUNG, MD, MILTON HOLLENBERG, MD, BRIAN F. O'KELLY, MB, 
ANN KAO, MD, DENNIS T. MANGANO, PHD, MD, and the SPI RESEARCH GROUP* 
San Francisco, California 
Objectives. Our study objective was to determine whether the 
presence of steal'prone anatomy conferred an increased risk in the 
development of intraoperative myocardial ischemia. 
Background. Coronary artery steal of collateral blood flow has 
been demonstrated for many vasodilators, including isoflurane, 
the most commonly used inhalational anesthetic agent in the 
United States. It has been postulated that patients with steal· prone 
anatomy (total occlusion of one coronary artery that is supplied 
distally by collateral flow from another coronary artery with a 
~50% stenosis) may be particularly at risk for the development of 
intraoperatil'e myocardial ischemia when an anesthetic with a 
vasodilator property is being administered. 
Methods. We evaluated the ~yocardial ischemia under 
isoflurane anesthesia (vs. a high dose' narcotic technique using 
sufentanil) using continuous intraoperative electrocardiography 
and transesophageal echocardiography in patients "ith and with-
out steal'prone anatomy undergoing coronary artery bypass graft 
surgery. 
Results. Sixty·two (33%) of the 186 patients had steal'prone 
anatomy: in 5 (8%) the collateral·supplying vessel was ~50% to 
69% stenosed, in 24 (39%) it was ~70% to 89% stenosed and in 
Coronary artery steal is defined as an increase in flow to 
nonischemic myocardium at the expense of decreasing col-
lateral flow to ischemic myocardium (1,2). Coronary steal of 
collateral blood flow has been suggested for many vasodila-
tors including dipyridamole (3-6) and adenosine (7). Isoflu-
rane, the most commonly used inhalational anesthetic agent 
in the United States, also has been implicated to produce 
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33 (53%) it was ~90% stenosed. The incidence of ischemia 
(transesophageal echocardiography or intraoperative electrocar· 
diography, or both) was similar in patients with and without 
steal'prone coronary anatomy (18 [29%] of 62 patients vs. 39 
[31 %] of 124 patients, p = 0.87,95% confidence interval = -0.13 
to 0.17). The incidence of intraoperative ischemia was simHar in 
patients who received isoflurane or sufentanil anesthesia (20 
[32%] of 62 patients vs. 37 [30%] of 124 patients, p = 0.87). The 
incidence of tachycardia and hypotension was low (increases in 
heart rate = 9.8%, and decreases in systolic blood pressure = 
10.8% of total monitoring time during the prebypass period 
compared with preoperative baseline values). The incidence of 
adverse cardiac outcome was similar in patients with and without 
preoperative steal· prone coronary anatomy (4 [7 %] of 62 patients 
\'s. 14 [11 %] of 124 patients, p = 0.53). 
Conclusions. These findings demonstrate that under strict 
hemodynamic control the presence of steal'prone anatomy does 
not confer an increased risk in the development of intraoperative 
myocardial ischemia. 
(J Am Coli CardioI1992;20:1205-12) 
coronary artery steal and myocardial ischemia. Isoflurane is 
a coronary vasodilator in both animals and humans (8-12), 
and it can cause redistribution of myocardial blood flow 
(intercoronary and transmural steal) in specific animal mod-
els (10,11). Ischemic changes (regional mechanical dysfunc-
tion and redistribution of myocardial blood flow) have been 
demonstrated in canine preparations (11,13) and an associa-
tion between isoflurane and markers of myocardial ischemia 
(electrocardiographic [ECG] and metabolic changes) has 
been observed in at-risk patients undergoing surgery (8,14-
16). 
Patients with "steal-prone anatomy" (total occlusion of 
one coronary artery that is supplied distally by collateral 
vessels from another coronary artery with a 2:50% stenosis) 
may be particularly at risk for the development of intraop-
erative myocardial ischemia when an anesthetic agent with 
vasodilator properties is being administered (17). Because 
>400,000 cardiac surgical procedures are performed annu-
ally in the United States and 7 million of 25 million noncar-
diac surgical procedures are performed in patients who have 
or are at risk for coronary artery disease (18), knowledge of 
the coronary anatomy may be an important part of preoper-
ative risk assessment. Additionally, if the presence of steal-
0735-10971921$5.00 
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prone anatomy does confer an increased risk for myocardial 
ischemia, then the use of certain anesthetic agents with 
vasodilator properties may be contraindicated. Thus, re-
stricting the use of an anesthetic agent such as isoflurane in 
these patients would involve a substantial change in current 
anesthetic practice. 
Although the safety of isoflurane has been suggested in 
patients undergoing surgery (19-22) the deleterious effects of 
isoflurane may be evident only in high risk patients with 
steal-prone anatomy (17). Thus, our study objective was to 
evaluate the risk of myocardial ischemia in patients with and 
without steal-prone anatomy under isoflurane anesthesia (vs. 
a high dose narcotic technique using sufentanil). Coronary 
anatomy was assessed by preoperative coronary angiogra-
phy and myocardial ischemia was measured by continuous 
intraoperative electrocardiography and transesophageal 
echocardiography. 
Methods 
Study group. After institutional approval and informed 
consent were obtained, 186 patients (185 men and I woman, 
37 to 79 years of age [mean ±SD 62 ± 9]) scheduled for 
elective coronary artery bypass graft surgery at the San 
Francisco Veterans Administration Medical Center between 
August 1987 and March 1990 were randomized to receive 
isoflurane or sufentanil anesthesia. The demographic and 
clinical data collected for each patient included a history of 
prior myocardial infarction, previous coronary artery bypass 
graft surgery or angioplasty, hypertension, diabetes mellitus, 
unstable angina and preoperative cardiac medications. Pre-
operative ejection fraction was determined by ventriculog-
raphy, and the number of significant coronary artery steno-
ses noted. Significant stenosis was defined as a ;::70% 
diameter stenosis of the left anterior descending, left circum-
flex or right coronary artery and a ;::50% diameter stenosis of 
the left main coronary artery. 
Coronary angiography. Coronary angiography was per-
formed with the Seldinger percutaneous technique. Ventric-
ulography was performed in the 30° right anterior oblique 
and 60° left anterior oblique projections. All patients' angio-
grams were analyzed for evidence of steal-prone anatomy, 
defined as total occlusion in one coronary artery that is 
supplied distally by collateral flow from another coronary 
artery with a >50% stenosis (17). Each study was reviewed 
by an investigator unaware of the research information 
obtained from the echocardiographic and specialized ECG 
monitoring. Stenoses were graded subjectively by visual 
assessment of the cineangiograms. Total occlusions were 
identified in the right coronary artery, and in the anterior 
descending and proximal circumflex branches of the left 
coronary artery. Next, angiographic evidence of collateral 
blood supply to the zone or zones beyond each total obstruc-
tion was identified. Finally, the number of angiograms in 
which the artery supplying the collateral vessels having a 
;::50% (diameter reduction) stenosis was determined. 
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Management of anesthesia. Measurements of heart rate 
and systolic blood pressure were obtained during the 48-h 
preoperative period while the patients were receiving 
maximal medical therapy. The baseline values of heart 
rate and systolic blood pressure were determined by aver-
aging the last five preoperative values obtained for each 
variable. Routine clinical monitors included seven-lead 
electrocardiography and radial artery and pulmonary artery 
catheters. The end-tidal isoflurane concentration was con-
tinuously monitored by mass spectrometry and the data 
were stored in a microcomputer. No clinician providing 
direct patient care had access to the research information 
obtained from the echocardiographic and specialized ECG 
monitoring. 
Patients received diazepam and morphine sulfate as pre-
anesthetic medication, and all cardiac medications were 
continued until the time of operation. Patients were random-
ized to receive either isoflurane or high dose sufentanil 
anesthesia by a random number-generated method. Sixty-
two patients received isoflurane and 124 patients received 
sufentanil. The number of patients in the two anesthetic 
groups was unequal because of a larger protocol in which 
these patients were involved. All patients received 100% 
inspired oxygen to maintain arterial partial pressure of 
oxygen (Pao2) >70 mm Hg, and ventilation was controlled to 
maintain arterial partial pressure of carbon dioxide (Paco2) 
between 35 and 45 mm Hg. 
The anesthesiologists were requested to maintain heart 
rate within ±20% and systolic blood pressure within ±20% 
of preoperative baseline values throughout the study (pre-
bypass) period. If the anesthesiologist judged that anesthetic 
depth was inadequate, inspired isoflurane concentration was 
increased; in those who received sufentanil, additional suf-
entanil was given. Any hemodynamic aberrations occurring 
in either group after increases in anesthetic depth were 
treated with vasodilators and beta-adrenergic blocking 
agents, as needed. The administration of all cardiovascular 
medications was recorded. 
Transesophageal echocardiography. Immediately after tra-
cheal intubation, a gastroscope tipped with either a 3.5-MHz 
(Diasonics Inc.) or a 5-MHz phased-array transducer (Gen-
eral Electric Co.) was introduced into the esophagus. The 
transducer was positioned and maintained at the level of the 
mid-papillary muscles to obtain a short-axis view of the left 
ventricle. Transesophageal echocardiographic data were re-
corded continuously onto videotape during the prebypass 
period (that is, from completion of tracheal intubation to the 
onset of cardiopulmonary bypass). 
The real-time videotape was edited to obtain samples for 
analysis. Echocardiographic samples of 6O-s duration were 
obtained every 15 min throughout the prebypass period. 
AdditionaIly, samples were obtained at other pre-specified 
times to detect whether anesthetic or surgicaIly imposed 
stresses had any immediate effect on regional wall motion. 
During the prebypass period, samples were obtained imme-
diately after tracheal intubation and at 4 min before, and I 
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and 6 min after each of the following surgical events: skin 
incision, sternotomy, pericardiotomy and aortic and right 
atrial cannulation. 
The short-axis, cross-sectional image was divided into 
four segments by using the papillary muscles as guides 
(23,24). This floating reference system compensated for 
translational and rotational movements of the heart. A 
segment was considered suitable for wall motion analysis if 
70% of its entire endocardial outline was visible continu-
ously throughout systole and diastole. All samples were 
visually analyzed by two investigators by consensus; these 
investigators had no knowledge of patient identity, clinical 
outcome or time of sampling. The wall motion of each of the 
four segments was graded as follows: 0 = normal, 1 = mild 
hypokinesia, 2 = severe hypokinesia with myocardial thick-
ening, 3 = akinesia, and 4 = dyskinesia. Myocardial thick-
ening was estimated by visual inspection in real time and 
slow motion. Each patient's best pre bypass wall motion 
score was used as his or her baseline score. A transesopha-
geal echocardiographic episode suggestive of ischemia was 
defined by regional wall motion worsening =::2 grades and 
lasting =:: 1 min. The interobserver variability for definition of 
a transesophageal echocardiographic ischemic episode was 
3% and intraobserver variability was 2% (for both observ-
ers). 
Electrocardiography. Electrocardiographic monitoring 
was performed by using a two-channel AM Holter ECG 
recorder (Marquette Electronics, series 8500) for 2 days 
preoperatively (baseline) and also from the time of induction 
of anesthesia to the onset of cardiopulmonary bypass. The 
frequency response met the American Heart Association 
specification for ST changes, the cutoff limit being 0.05 Hz 
for low frequency and 80 Hz for high frequency. Two bipolar 
leads, CCs and modified CMs, were used. Each complete 
ECG recording on Holter tape was scanned visually using an 
ECG analysis system (Marquette series 8000). All abnormal 
QRS complexes (for example, ventricular ectopic beats and 
conduction abnormalities) were excluded. A continuous 
two-lead ST segment trend was then generated for the entire 
tape. The baseline ST segment level was defined as the 
average ST segment during a stable period (usually 1 h) 
preceding each episode. All possible ischemic episodes were 
reviewed and verified by two investigators who had no 
knowledge of patient identity and outcome. An ECG isch-
emic episode was defined as reversible ST depression 
=::0.1 mV from baseline at J + 60 ms, or >0.2 mV ST 
elevation at the J point lasting for at least 1 min. During 
tachycardia when J + 60 ms fell within the T wave, the time 
after the J point was shortened to a minimum of J + 40 ms. 
The characteristics of each ECG ischemic episode including 
the magnitude (ST segment), episode duration, severity 
(area under the ST time-curve), as well as the ischemic 
burden (min of ischemialh monitored) also were determined. 
Hemodynamics. Intraoperatively, systolic and diastolic 
blood pressures were continuously measured with the use of 
radial artery catheters in all 186 patients. Heart rates were 
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derived from the ECG tracings. Pulmonary artery systolic 
and diastolic pressures were continuously measured in 183 
patients (3 patients did not have interpretable tracings). The 
zero reference point was located 5 cm posterior to the sternal 
angle in a direction perpendicular to the frontal plane of the 
chest. Systolic, diastolic, mean arterial and pulmonary ar-
tery pressures and heart rate were measured continuously on 
entry into the operating room and the data stored in a 
microcomputer (Toshiba Tlooo, Toshiba Corporation) with 
the use of a digital interface system. All hemodynamic data 
also were recorded continuously onto hard copy at 1 mmls 
with a four-channel strip chart recorder (Marquette, 4-Inch 
Direct Digital Writer) linked to the hemodynamic monitor 
(Marquette 7010, frequency response 0.05 to 120 Hz). He-
modynamic data were averaged every 60 s and entered into 
the microcomputer. The time clocks on transesophageal 
echocardiography, the Holter monitor and hemodynamic 
recorder were synchronized before induction of anesthesia. 
The hemodynamic data were analyzed as follows: 1) heart 
rate, systolic blood pressure, diastolic blood pressure and 
pulmonary artery diastolic pressure were sampled from the 
computer every 60 s; 2) data on the hard copy were reviewed 
to ensure that artifacts (such as erroneous values resulting 
from blood drawing or flushing of catheters) were excluded 
from analysis; and 3) the data were entered into a computer 
spreadsheet (Statview 512+, Brainpower) and the frequency 
distributions for heart rate and systolic blood pressure were 
determined for the entire prebypass period for each patient. 
We defined significant hemodynamic changes as >20% 
increases in heart rate, systolic blood pressure or pulmonary 
diastolic pressure or >20% decreases in systolic or diastolic 
blood pressure. 
Operative technique. Cardiopulmonary bypass was per-
formed using a bubble oxygenator and hemodilution and 
moderate systemic hypothermia (26° to 28°C). Multidose 
cold blood (8°C, hematocrit 20% to 25%) with potassium 
cardioplegia (20 mEqlliter) and topical saline/ice slush were 
used for myocardial protection during cardiopulmonary by-
pass. Distal anastomoses were performed during continuous 
aortic cross-clamping, followed by proximal vein grafting 
during partial aortic occlusion. One hundred seventy-seven 
patients received a vein graft and 177 patients received an 
internal mammary artery graft to either the left anterior 
descending or the first diagonal coronary artery. The peri-
cardium was left open in all patients. 
The quality of the bypass grafts was assessed by surgeons 
who were unaware of the echocardiographic and hemody-
namic findings. The grafts were graded qualitatively as poor, 
fair, very good and excellent. 
Outcome measurements. Both 12-lead electrocardiog-
raphy and creatine kinase (CK) MB isoenzyme concen-
trations were obtained preoperatively (control) and daily 
for the 1st 3 postoperative days. Adverse major outcomes 
were myocardial infarction, ventricular failure or cardiac 
death. These were defined as 1) myocardial infarction-new 
Q waves (=::40 ms, or =::25% of the R wave in lead a VF) on 
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Table 1. Clinical Data in 186 Patients 
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Patients With Patients Without 
Steal-Prone Anatomy Steal-Prone Anatomy 
(n = 62) 
Age (yr) 62:!: 9 
Prior myocardial infarction 40 (65) 
PriorCABG 4 (7) 
Prior angioplasty 3 (5) 
Hypertension 39 (63) 
Diabetes melIitus 13 (21) 
Unstable angina 30 (48) 
(n = 124) 
62:!: 8 
76 (61) 
8 (7) 
16 (13) 
71 (57) 
35 (28) 
79 (64) 
p Value 
0.84 
0.79 
0.75 
0.15 
0.56 
Preoperative EF by angiography 53%:!: 13% 54%:!: 15% 
. 0.37 
0.Q7 
0.60 
Medications 
Nitrates 58 (94) 
Calcium channel blocking agents 50 (81) 
Beta-adrenergic blocking agents 36 (58) 
114 (92) 
106 (86) 
63 (51) 
0.92 
0.53 
0.44 
Data are expressed as mean value:!: I SD or number (%) of patients in each subgroup. CABG = coronary artery 
bypass grafting; EF = ejection fraction. 
the 12-lead ECG alld MB CK concentration ;::50 Uniter; 
2) ventricular failure-cardiac index <2 liters'min- I 'm-2 
requiring an intraaortic balloon pump; and 3) cardiac death-
death attributed to cardiac cause during the period of hospi-
talization. A cardiac cause was defined as either myocardial 
infarction, arrhythmia or ventricular failure due to a cardiac 
condition. 
Statistical methods. Chi-square analysis with continuity 
correction was applied to categoric data. A Student t test 
was used to test the difference between the means in the two 
groups. Nonparametric data were assessed by Mann-
Whitney U test. Differences in heart rate and blood pressure 
were assessed by one-way analysis of variance with the use 
of repeated measures. A p value < 0.05 (two-sided) identi-
fied significant differences. 
Results 
Overall, the demographic data and preoperative medica-
tions were similar in patients with or without steal·prone 
anatomy (Table 1). 
Hemodynamics. Intraoperative hemodynamic variables 
were well controlled. The incidence of tachycardia and 
hypotension was low (increases in heart rate = 9.8%, and 
decreases in systolic blood pressure = 10.8% of total mon-
itoring time during the pre bypass period compared with 
preoperative baseline values) and was not different between 
patients with and without steal-prone anatomy. 
Anatomy. Fifty-five percent of patients (103 of 186) had 
100% occlusion of at least one major coronary artery. 
Twenty-two percent (41 of 186) had 100% occlusion of at 
least one major artery but had either no collateral vessels or 
collateral vessels supplied by an ipsilateral vessel or by a 
vessel <50% stenosed. Sixty-two (33%) of the 186 patients 
had steal-prone anatomy. Of these 62 patients, 5 (8%) had 
collateral vessels supplied by a coronary artery that was 
;::50% to 69% stenosed, 24 (39%) had collateral vessels 
supplied by a coronary artery that was ;::70% to 89% 
stenosed, and 33 (53%) had collateral vessels supplied by a 
coronary artery that was ;::90% stenosed. 
Myocardial ischemia. The incidence of ischemia as as-
sessed by transesophageal echocardiography or intraopera-
tive electrocardiography, or both, was similar in patients 
with and without steal-prone anatomy (18 [29%] of 62 
patients vs. 39 [31%] of 124 patients, p = 0.87, 95% confi-
dence interval -0.13 to 0.17). The incidence of ischemia was 
similar in patients who received isoflurane or sufentanil 
anesthesia (20 [32%] of 62 patients vs. 37 [30%] of 124 
patients, p = 0.87). In the isoflurane group, 42% (26 of 62) of 
patients had steal-prone anatomy, with 8 (31%) of these 
manifesting ischemia on electrocardiography or transesoph-
ageal echocardiography, or both. In the sufentanil group, 
29% (36 of 124) had steal-prone anatomy, with 10 (28%) 
developing ischemia (p = 0.98 vs. isoflurane group). 
The characteristics of transesophageal echocardiographic 
and of ECG episodes did not differ significantly between the 
patients with or without steal-prone anatomy (Table 2). 
The distribution of transesophageal echocardiographic 
ischemic episodes at the level of the short axis is shown in 
Figure 1. Intraoperative transesophageal echocardiographic 
ischemic episodes occurred frequently in the area at risk 
determined by preoperative coronary angiography. Ninety-
one percent of the new intraoperative prebypass regional 
wall motion abnormalities occurred in regions supplied by a 
critically stenosed (>70%) coronary artery. Forty-four per-
cent of the transesophageal echocardiographic ischemic ep-
isodes occurred in the myocardium supplied by the right 
coronary artery, 36.6% occurred in regions supplied by the 
left anterior descending artery and 19.5% in regions supplied 
by the left circumflex artery. 
Other factors. The concentration of isoflurane did not 
appear to influence the risk of developing intraoperative 
myocardial ischemia. The mean end-tidal isoflurane concen-
tration was similar in patients who did and did not develop 
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Table 2. Characteristics of Ischemic Episodes Identified With Transesophageal Echocardiography 
and Intraoperative Electrocardiography Before Institution of Cardiopulmonary Bypass 
Patients With Patients Without 
Steal-Prone Steal-Prone 
Coronary Anatomy Coronary Anatomy 
(n = 62) (n = 124) p Value 
Transesophageal echocardiography 
Incidence of ischemia (%) 21 22 0.91 
Mean duration (min) 15 ± \3 28 ± 25 0.07 
Mean change in WMS +2.1 ± 0.8 +2.8 ± 1.3 0.08 
Duration of monitored ischemia (minlh) 9.9 ± 8.3 15.7 ± 12 0.17 
Electrocardiography 
Incidence of ischemia (%) 18 19 0.95 
Mean ST segment depression (mm) -1.7 ± 1.3 -1.33 ± 1.06 0.\3 
Mean duration (min) 36.0 ± 24.2 41.7 ± 28.2 0.88 
Mean AUC (mm·min) -58.7 ± 62.1 -37.2 ± 51.6 0.2 
Duration of monitored ischemia (minlh) 16.1 ± 9.9 18.3 ± 11.7 0.66 
Values are expressed as percent or as mean value ± 1 SD. AUC = area under the curve, a measure that provides 
an estimate of the severity of an electrocardiographic ischemic episode; WMS = wall motion score. The wall motion· 
of each of the four segments of the left ventricle at the level of the short axis was graded according to a 5-point scale 
(see text). A transesophageal echocardiographic episode suggestive of ischemia was defined by regional wall motion 
~2 grades and lasting ~ 1 min. 
transesophageal echocardiographic ischemia (0.90% vs. 
0.88%, p = 0.89). In fact, transesophageal echocardio-
graphic ischemic episodes occurred at both low (0.47%) and 
high (1.75%) concentrations of isoflurane. 
The intraoperative drug data are summarized in Table 3. 
Patients who had steal-prone coronary anatomy were given 
significantly more ephedrine and neosynephrine to maintain 
Figure 1. Percent distribution of all ischemic episodes observed 
with transesophageal echocardiography is shown in the posterior, 
septal, anterior and lateral segments of the left ventricular short-axis 
view. 
so 
40 
30 
20 
10 
o 
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blood pressure. Patients who were randomized to receive 
isoflurane anesthesia also received significantly more ephed-
rine and neosynephrine to control blood pressure than those 
randomized to receive sufentanil anesthesia. However, in 
the 1 st 24 h postoperatively, neither the incidences or the 
dose ranges of the vasoactive agents used in the two groups 
were different. The number of grafts, total aortic cross-
clamp time and cardiopulmonary bypass time and the sur-
geon's overall assessment of the grafts were similar in 
patients receiving isoflurane or sufentanil (Table 4). The 
incidence of adverse cardiac outcome also was similar in 
patients regardless of their preoperative coronary anatomy. 
Five (8%) of the 62 patients with steal-prone anatomy had an 
adverse cardiac outcome, compared with 14 (11%) of the 124 
patients without steal-prone anatomy (p = 0.67). 
Table 3. Intraoperative Drug Data in 186 Patients 
Patients With Patients Without 
Steal-Prone Steal-Prone 
Coronary Anatomy Coronary Anatomy 
(n = 62) (n = 124) p Value 
Dopamine 1 (1.6) 0 0.73 
Ephedrine 23 (37) 27 (22) 0.04 
Neosynephrine 48 (77) 71 (57) 0.01 
Nitroglycerin 24 (39) 35 (29) 0.24 
Nitroprusside 1 (1.6) 7 (6) 0.35 
Calcium channel 2 (3) 0 0.22 
blocking agents 
Beta-adrenergic 6 (10) 14 (11) 0.93 
blocking agents 
Diazepam 60 (97) 118 (95) 0.90 
Fentanyl 24 (39) 37 (30) 0.29 
Sodium thiopental 24 (39) 33 (28) 0.16 
Data are presented as number (%) of patients in each subgroup. 
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Table 4. Surgical and Outcome Data in 186 Patients 
Surgical data 
Grafted vessels 
No. 
Range 
Aortic cross-clamp time (min) 
Cardiopulmonary bypass time (min) 
Surgical assessment 
Grade 4 (excellent) 
Grade 3 (good) 
Grade 2 (fair) 
Grade I (poor) 
Outcome data 
Myocardial infarction 
Ventricular failure 
Cardiac death 
Total outcome 
Patients With 
Steal-Prone 
Coronary 
Anatomy 
(n = 62) 
3 
I to 5 
57:!: 16 
97:!: 27 
18 (32) 
25 (45) 
12 (21) 
I (2) 
3 (5) 
1(2) 
I (2) 
5 (8) 
Patients Without 
Steal-Prone 
Coronary 
Anatomy 
(n = 124) 
3 
I to 5 
60:!: 17 
106 :!: 31 
24 (21) 
61 (52) 
30 (26) 
2 (2) 
8 (6) 
3 (2) 
3 (2) 
14 (t I) 
Data are expressed as mean value:!: I SD or number (%) of patients in 
each subgroup. 
Discussion 
Our study demonstrated that under strict hemodynamic 
control, the presence of steal-prone anatomy does not in-
crease the risk of developing intraoperative myocardial 
ischemia. These data also suggest that in patients with 
steal-prone coronary anatomy, the use of an anesthetic agent 
such as isoflurane, which posses;es vasodilator properties, 
does not appear to confer additional risk. 
Comparison with previous studies. A review of coronary 
angiograms in 16,249 patients who participated in the Coro-
nary Artery Surgery Study (CASS) demonstrated that 23% 
of the patients had steal-prone coronary anatomy (17). It has 
been suggested that studies examining clinical evidence of 
adverse effects from coronary steal must be done in the 
subsets of patients with coronary artery disease with steal-
prone anatomy. 
Does the presence of steal-prone coronary anatomy in-
crease the risk of intraoperative myocardial ischemia? In a 
randomized trial of the use of one of four anesthetic. agents 
for coronary artery bypass graft surgery, Slogoff et al. (25) 
suggested that the incidence of ECG ischemia did not differ 
between patients with and without steal-prone anatomy. 
However, their study was limited by a lack of hemodynamic 
control, as reflected by a rather high incidence of hemody-
namic aberrations (86% of their patients had a systolic blood 
pressure> 180 or <90 mm Hg or a heart rate >90 beats/min). 
Because hemodynamic aberrations such as tachycardia or 
hypotension may independently precipitate myocardial isch- . 
emia, Slogoff et al. (25) cannot assess the direct effect of 
preoperative coronary anatomy. In our study, when we 
rigorously controlled hemodynamic variables, the incidence 
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of transesophageal echocardiographic or ECG ischemia was 
similar regardless of the preoperative coronary anatomy. 
The low incidence of heart rate and blood pressure abnor-
malities in our study allows a direct determination of the role 
of steal-prone anatomy in influencing the risk of myocardial 
ischemia development without the confounding effects of 
hemodynamic changes. 
Reasons for lack of increased risk for myocardial ischemia 
in present patients with steal-prone anatomy. The conditions 
previously described for vasodilator-induced coronary steal 
include 1) an arteriolar-type dilator like dipyridamole, and 
2) stenoses of the arteries supplying collateral flow to the 
ischemic region (26). Isoflurane has been demonstrated to 
dilate predominantly coronary arterioles in the canine model 
(9) and thus potentially has properties similar to those of 
dipyridamole. The vasodilator effect of isoflurane on small 
resistance vessels would therefore be ,capable of causing 
maldistribution of coronary blood flow. By definition, our 
patients with steal-prone anatomy had stenoses of arteries 
supplying collateral flow to an ischemic region. In fact, 53% 
of the patients with steal-prone anatomy had a collateral-
supplying vessel that was =::90% stenosed. 
Role of isoflurane. Why, then, did we not observe an 
increased incidence of myocardial ischemia with isoflurane 
in patients with steal-prone anatomy? Several possible ex-
planations exist. First, isoflurane is only a mild coronary 
vasodilator (12). Although one MAC (minimal alveolar con-
centration) of isoflurane produced an increase in coronary 
blood flow, this increase was extremely small (26%) com-
pared with the 400% increase in absolute coronary blood 
flow induced by the potent coronary vasodilator adenosine 
in awake dogs (12). If isoflurane is a weak coronary vasodi-
lator, then a much higher concentration (in excess of that 
used clinically and not tested in this current study) may be 
necessary to impair coronary autoregulation. 
Role of perfusion pressure. Second, conditions in which 
isoflurane are associated with myocardial ischemia fre-
quently involve significant hypotension (8,16,18). Induction 
of anesthesia in these studies typically resulted in a 30% to 
45% decrease in coronary perfusion pressure. Therefore, it 
is difficult to distinguish between reductions in coronary 
perfusion pressure and a redistribution of blood flow within 
the myocardium as the cause of ischemia in these studies. 
Two reports demonstrated the importance of perfusion pres-
sure when studying the potential for any agent to cause 
ischemia in a poststenotic or a collateral flow-dependent 
myocardium. Cason et al. (27) demonstrated that in a canine 
preparation, coronary steal did not occur in the collateral-
supplied myocardium when coronary perfusion pressure was 
kept constant by aortic constriction. Conzen et al. (28) 
similarly found that isoflurane induced hypotension and 
decreased blood flow and tissue oxygen pressures of collat-
eral flow-dependent myocardial areas in dogs. However, 
neither isoflurane nor dipyridamole caused such alterations 
when arterial pressure was normal. 
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Role of ephedrine and neosynephrine. Third, patients 
with steal-prone anatomy received significantly more neo-
synephrine or ephedrine, or both, to maintain blood pressure 
in our study. Such agents with alpha-agonist properties may 
be protective for the myocardium at risk. In a canine model, 
Feigl et al. (29) increased sympathetic activity by intracoro-
nary infusion of norepinephrine in the presence of a 70% 
area reduction stenosis of the left main coronary artery. 
They observed nearly uniform transmural adrenergic coro-
nary vasoconstriction even during coronary underperfusion. 
The persistence of alpha-receptor mediated coronary vaso-
constriction during coronary underperfusion was thought to 
have an anti transmural steal action during myocardial isch-
emia. These investigators hypothesized that alpha-receptor-
mediated coronary vasoconstriction in the outer layers of the 
left ventricle retards the subepicardial steal of flow from 
inner to outer layers that occurs during ischemia. Hence, it 
is conceivable that the increased use of neosynephrine in our 
patients with steal-prone anatomy may have a beneficial 
effect in reducing the incidence of ischemia. Similarly, 
because patients randomized to receive isoflurane also re-
ceived more ephedrine and neosynephrine to control blood 
pressure than did those randomized to receive sufentanil 
anesthetic, these agents may have mitigated the vasodilator 
effect of isoflurane. 
Clinical implications. Our study demonstrated that the 
incidence of intraoperative myocardial ischemia was similar 
in patients with or without steal-prone anatomy. Further-
more, the choice of an anesthetic agent with vasodilator 
properties also did not influence the incidence of myocardial 
ischemia. Specifically, there is no evidence that isoflurane, 
an anesthetic agent and a vasodilator, should be restricted in 
patients with coronary artery disease, including those with 
steal-prone anatomy if systemic hemodynamic variables are 
carefully controlled. Additionally, because isoflurane lowers 
myocardial oxygen consumption (30), this reduction may 
have a protective effect on the myocardium at risk, negating 
the effect of coronary steal. Our results also support the 
importance of controlling perfusion pressure when studying 
the potential for any agent to cause myocardial ischemia. 
Limitations of the study. Our results do not exclude the 
potential of isoflurane to induce coronary steal because our 
study was not designed to investigate this phenomenon. 
Rather, we studied whether the risk of myocardial ischemia 
was increased in patients with steal-prone anatomy under 
isoflurane anesthesia. If the risk of myocardial ischemia and 
adverse cardiac outcomes was not increased under isoflu-
rane anesthesia, then the presence of coronary steal induced 
by isoflurane under these conditions is clinically unimpor-
tant. 
We did not prospectively randomize patients into receiv-
ing isoflurane or sufentanil anesthesia according to their 
presence or absence of steal-prone anatomy. However, the 
preoperative demographic factors as well as the intraopera-
tive surgical characteristics were not different between pa-
tients with and without steal-prone anatomy. Whether our 
LEUNG ET AL. 1211 
STEAL-PRONE ANATOMY AND MYOCARDIAL ISCHEMIA 
results hold in higher risk patients (those with poorer ven-
tricular function, prior aortocoronary bypass surgery or 
angioplasty) remain to be proved. 
Additionally, we did not investigate whether higher con-
centrations of isoflurane induce myocardial ischemia. Our 
study design was to investigate whether isoflurane used as a 
primary anesthetic agent (in standard clinical concentra-
tions) increased the risk of myocardial ischemia. Our study 
does not exclude the possibility that isoflurane used as the 
sole agent may increase the incidence of myocardial isch-
emia in patients with or without steal-prone anatomy. 
Finally, angiographically visible collateral channels rep-
resent only a fraction of collateral circuitry. With angiogra-
phy, we can only visualize channels> 100 JIm in diameter, 
giving no insight regarding the microcirculation (31). There is 
also evidence from contrast echocardiography that collateral 
channels not visualized on angiography were evident from 
contrast injection (32). Furthermore, this epicardial arcade 
of vessels may not reflect the presence of intramyocardial 
collateral circulation. In fact, the development of angio-
graphic collateral channels has been shown to be a very 
dynamic occurrence (33). Therefore, the term "steal-prone 
anatomy" is an oversimplification of the coronary anatomy. 
Summary. In summary, our study demonstrated that 
under strict hemodynamic control, i.e., when heart rate and 
blood pressure are controlled within narrow limits, the pres-
ence of steal-prone anatomy does not increase the incidence of 
intraoperative myocardial ischemia or adverse cardiac out-
come. Additionally, the choice of an anesthetic agent with 
vasodilator properties, such as isoflurane, does not appear to 
confer additional risk in patients with steal-prone anatomy 
under conditions of strict hemodynamic control. 
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